| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $39.3M | +20.9% |
| SG&A Expense | $14.8M | +7.4% |
| Operating Income | -$54.1M | -16.9% |
| Net Income | -$53.0M | -14.4% |
| EPS (Basic) | -$1.81 | -0.6% |
| EPS (Diluted) | -$1.81 | -0.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $81.6M | -33.2% |
| Short-term Investments | $24.9M | — |
| Current Assets | $108.8M | -12.6% |
| Total Assets | $117.0M | -7.4% |
| Current Liabilities | $9.5M | +13.2% |
| Total Liabilities | $12.4M | +48.5% |
| Stockholders' Equity | $104.5M | -11.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$46.4M | -36.0% |
| Capital Expenditures | $2.5M | +110.4% |
| Investing Cash Flow | -$27.2M | -553.7% |
| Financing Cash Flow | $33.0M | -32.6% |
| Free Cash Flow | -$48.8M | -38.4% |